Examination with PET/ MRI for patients with laryngeal cancer.
Imaging with PET/MRI is useful for primary staging of laryngeal cancer, according to a study in the European Journal of Radiology.
Researchers from Italy sought to assess the clinical impact of PET/MRI examination on patients with histologically proven laryngeal cancer, and their staging and treatment planning.
Sixteen patients underwent whole body PET/CT followed by a dedicated head/neck PET/MRI. Two blinded groups evaluated the data: metabolic (SUV and MTV), diffusion (ADC) and perfusion (Ktrans, Ve, kep, and iAUC) maps were obtained by positioning regions of interest (ROIs). Tumoral local extension assessed on PET/MRI was compared to endoscopic findings.
The results showed a good interobserver agreement in anatomical location and local extension of PET/MRI lesions. “PET/CT SUV measures highly correlate with ones derived by PET/MRI (eg, pâ =â 0.96 for measures on VOI),” the authors wrote. “Significant correlations among metabolic, diffusion and perfusion parameters have been detected.” The researchers noted that PET/MRI had a relevant clinical impact, confirming endoscopic findings (six cases), helping treatment planning (nine cases), and modifying endoscopic primary staging (one case).
The researchers concluded that use of PET/MRI in primary staging of laryngeal cancer allowed simultaneous collection of metabolic and functional data and conditioning the therapeutic strategies.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.